How to determine if elderly people can receive albumin injections
Albumin levels can be checked through liver function tests to determine whether elderly individuals should receive albumin therapy. If the level is within the normal range, albumin supplementation is generally unnecessary. However, if the level is significantly below the normal range, albumin supplementation may be required.
Albumin is an important protein in human blood plasma, produced by the liver. It is a colloid substance that helps maintain nutritional status and osmotic pressure in the body, ensuring stability of blood within the blood vessels. The normal range for albumin is 35–55 g/L. Elderly individuals can undergo liver function testing to assess their albumin levels. If levels are within the normal range, albumin injections are typically not needed. Since albumin is a blood-derived product, it carries a potential risk of transmitting viral diseases; therefore, it should not be administered when levels are already normal. However, if liver function tests show albumin levels below 30 g/L, especially accompanied by symptoms such as swelling or thrombosis, albumin therapy may be used to help alleviate these symptoms.
In addition, some individuals may be particularly sensitive to albumin and may experience side effects after injection, such as nausea, fever, or rash. Therefore, albumin should not be used indiscriminately and must be administered under the guidance of a physician.